90921-60-1

Basic information

• Product Name: N-(2-FURYLMETHYL)-N-(THIEN-2-YLMETHYL)AMINE
• Synonyms: (2-furylmethyl)(2-thienylmethyl)amine(SALTDATA: HCl);(2-furylmethyl)(2-thienylmethyl)amine
• CAS NO: 90921-60-1
• Molecular Formula: C₁₀H₁₁NOS
• Molecular Weight: 193.27
• Mol File: 90921-60-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 279.5°Cat760mmHg
• Flash Point: 122.8°C
• Appearance: /
• Density: 1.178g/cm³
• Vapor Pressure: 0.00401mmHg at 25°C
• Refractive Index: 1.579
• CAS DataBase Reference: N-(2-FURYLMETHYL)-N-(THIEN-2-YLMETHYL)AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-FURYLMETHYL)-N-(THIEN-2-YLMETHYL)AMINE(90921-60-1)
• EPA Substance Registry System: N-(2-FURYLMETHYL)-N-(THIEN-2-YLMETHYL)AMINE(90921-60-1)

Safety Data

• Hazardous Substances Data: 90921-60-1(Hazardous Substances Data)

Usage

General Description

N-(2-Furylmethyl)-N-(thien-2-ylmethyl)amine is a chemical compound that consists of a furylmethyl group and a thien-2-ylmethyl group linked to an amine functional group. It is used in organic and pharmaceutical synthesis, and can also be employed as a reagent in various chemical reactions. N-(2-FURYLMETHYL)-N-(THIEN-2-YLMETHYL)AMINE has potential applications in drug design and development, as well as in the study of organic and medicinal chemistry. Additionally, its unique structure and properties may make it useful in the development of new materials or in the production of specialty chemicals.

InChI:InChI=1/C10H11NOS/c1-3-9(12-5-1)7-11-8-10-4-2-6-13-10/h1-6,11H,7-8H2

Upstream product

• 94096-05-6 furfurylidene-thiophen-2-ylmethyl-amine 
• 98-01-1 furfural 
• 27757-85-3 2-Aminomethylthiophene 
• 98-03-3 thiophene-2-carbaldehyde 
• 617-89-0 furan-2-ylmethanamine 

Downstream Products

• 1681056-61-0 (R)-N-(furan-2-ylmethyl)-2-(2-methoxyphenyl)-2-(2-oxo-1,2-dihydroquinoline-6-sulfonamido)-N-(thiophen-2-ylmethyl)acetamide 

Relevant articles and documents

O-GLCNAC TRANSFERASE INHIBITORS AND USES THEREOF

Provided herein are O-GlcNAc transferase (OGT) inhibitor compounds of Formula (I'), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or preventing diseases (e.g., diabetes and complications thereof, neurodegenerative diseases, proliferative diseases such as cancers, autoimmune diseases, and inflammatory diseases) in a subject. Provided are methods of inhibiting OGT in a subject or biological sample.

Sulfonic acid supported on hydroxyapatite-encapsulated-γ-Fe 2O3 nanocrystallites as a magnetically separable catalyst for one-pot reductive amination of carbonyl compounds

A novel, environmentally friendly procedure has been developed for the preparation of secondary or tertiary amines by one-pot reductive amination of carbonyl compounds using sodium borohydride in the presence of a magnetically recoverable sulfonic acid supported on hydroxyapatite-encapsulated-γ- Fe2O3 [γ-Fe2O3@HAP-SO 3H] at room temperature. The catalyst was easily separated from the reaction mixture by applying an external magnet and reused for six cycles without significant loss of catalytic activity.

PROCESS FOR PREPARING QUINUCLIDINIUM CARBAMATE DERIVATIVES

The invention relates to a new process for preparing carbamate derivatives having the structure of formula (I) by reacting, in a first step, a compound of formula (II) with a compound of formula (III) and reacting the product of this first step with an ac